CN104267109A - Radix bupleuri medicinal material detection method - Google Patents
Radix bupleuri medicinal material detection method Download PDFInfo
- Publication number
- CN104267109A CN104267109A CN201410374865.4A CN201410374865A CN104267109A CN 104267109 A CN104267109 A CN 104267109A CN 201410374865 A CN201410374865 A CN 201410374865A CN 104267109 A CN104267109 A CN 104267109A
- Authority
- CN
- China
- Prior art keywords
- solution
- medicinal material
- saikosaponin
- measuring
- precisely
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000463 material Substances 0.000 title claims abstract description 40
- 238000001514 detection method Methods 0.000 title claims abstract description 21
- 238000000034 method Methods 0.000 claims abstract description 28
- 239000000447 pesticide residue Substances 0.000 claims abstract description 26
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 54
- 239000000243 solution Substances 0.000 claims description 49
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 39
- 239000000575 pesticide Substances 0.000 claims description 33
- QLPRYZXNWYTFCI-UHFFFAOYSA-N saikosaponin D Natural products CC1OC(OC2CCC3(C)C(CCC4(C)C3C=CC56OCC7(CCC(C)(C)CC57)C(O)CC46C)C2(C)CO)C(O)C(O)C1OC8OC(CO)C(O)C(O)C8O QLPRYZXNWYTFCI-UHFFFAOYSA-N 0.000 claims description 32
- PQPVAGWUNWFCJE-UHFFFAOYSA-N saikosaponin a Natural products CC1OC(OC2CCC3(C)C(C2)C(C)(CO)CC4(C)C3C=CC56OCC7(CCC(C)(C)CC57)C(O)CC46C)C(O)C(OC8OC(CO)C(O)C(O)C8O)C1O PQPVAGWUNWFCJE-UHFFFAOYSA-N 0.000 claims description 32
- 241000202726 Bupleurum Species 0.000 claims description 31
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 22
- 239000012071 phase Substances 0.000 claims description 21
- KYWSCMDFVARMPN-MSSMMRRTSA-N Saikosaponin A Chemical compound O([C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@]([C@H]3[C@]([C@@H]4[C@@]([C@@]5(C[C@H](O)[C@]67CO[C@]5([C@@H]6CC(C)(C)CC7)C=C4)C)(C)CC3)(C)CC2)(C)CO)O[C@@H]([C@@H]1O)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O KYWSCMDFVARMPN-MSSMMRRTSA-N 0.000 claims description 19
- -1 phosphamidol Chemical compound 0.000 claims description 18
- 239000000523 sample Substances 0.000 claims description 18
- 238000005303 weighing Methods 0.000 claims description 16
- KYWSCMDFVARMPN-LCSVLAELSA-N Saikosaponin D Chemical compound O([C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@]([C@H]3[C@]([C@@H]4[C@@]([C@@]5(C[C@@H](O)[C@]67CO[C@]5([C@@H]6CC(C)(C)CC7)C=C4)C)(C)CC3)(C)CC2)(C)CO)O[C@@H]([C@@H]1O)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O KYWSCMDFVARMPN-LCSVLAELSA-N 0.000 claims description 14
- 238000005227 gel permeation chromatography Methods 0.000 claims description 13
- 238000002156 mixing Methods 0.000 claims description 13
- 229930195126 picroside Natural products 0.000 claims description 12
- KEUKDVIGAVVGLF-RUYHYXBRSA-N picroside I Natural products OC[C@]12O[C@H]1[C@@H]3O[C@@H](O[C@@H]4O[C@H](COC(=O)C=Cc5ccccc5)[C@@H](O)[C@H](O)[C@H]4O)C=C[C@@H]3[C@H]2O KEUKDVIGAVVGLF-RUYHYXBRSA-N 0.000 claims description 12
- AKNILCMFRRDTEY-UHFFFAOYSA-N picroside II Natural products C1=C(O)C(OC)=CC(C(=O)OC2C3C(C(OC=C3)OC3C(C(O)C(O)C(CO)O3)O)C3(CO)OC32)=C1 AKNILCMFRRDTEY-UHFFFAOYSA-N 0.000 claims description 12
- CUOKHACJLGPRHD-BXXZVTAOSA-N D-ribono-1,4-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H]1O CUOKHACJLGPRHD-BXXZVTAOSA-N 0.000 claims description 11
- 239000000706 filtrate Substances 0.000 claims description 11
- 238000004458 analytical method Methods 0.000 claims description 10
- 239000007789 gas Substances 0.000 claims description 10
- 238000002347 injection Methods 0.000 claims description 10
- 239000007924 injection Substances 0.000 claims description 10
- 238000012360 testing method Methods 0.000 claims description 10
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 9
- UOAMTSKGCBMZTC-UHFFFAOYSA-N dicofol Chemical compound C=1C=C(Cl)C=CC=1C(C(Cl)(Cl)Cl)(O)C1=CC=C(Cl)C=C1 UOAMTSKGCBMZTC-UHFFFAOYSA-N 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 9
- 239000012088 reference solution Substances 0.000 claims description 9
- 239000013558 reference substance Substances 0.000 claims description 9
- 239000000600 sorbitol Substances 0.000 claims description 9
- 239000011550 stock solution Substances 0.000 claims description 9
- 238000003860 storage Methods 0.000 claims description 9
- 238000009210 therapy by ultrasound Methods 0.000 claims description 9
- XZZNDPSIHUTMOC-UHFFFAOYSA-N triphenyl phosphate Chemical compound C=1C=CC=CC=1OP(OC=1C=CC=CC=1)(=O)OC1=CC=CC=C1 XZZNDPSIHUTMOC-UHFFFAOYSA-N 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 8
- 239000003223 protective agent Substances 0.000 claims description 8
- 239000012085 test solution Substances 0.000 claims description 8
- 239000003153 chemical reaction reagent Substances 0.000 claims description 7
- LCCNCVORNKJIRZ-UHFFFAOYSA-N parathion Chemical compound CCOP(=S)(OCC)OC1=CC=C([N+]([O-])=O)C=C1 LCCNCVORNKJIRZ-UHFFFAOYSA-N 0.000 claims description 7
- RLBIQVVOMOPOHC-UHFFFAOYSA-N parathion-methyl Chemical compound COP(=S)(OC)OC1=CC=C([N+]([O-])=O)C=C1 RLBIQVVOMOPOHC-UHFFFAOYSA-N 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 7
- 239000000047 product Substances 0.000 claims description 7
- 238000000746 purification Methods 0.000 claims description 7
- BAZVSMNPJJMILC-STQMWFEESA-N (1s,2r)-1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butan-2-ol Chemical compound O([C@@H]([C@H](O)C(C)(C)C)N1N=CN=C1)C1=CC=C(Cl)C=C1 BAZVSMNPJJMILC-STQMWFEESA-N 0.000 claims description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 6
- 238000007865 diluting Methods 0.000 claims description 6
- 238000010828 elution Methods 0.000 claims description 6
- RDYMFSUJUZBWLH-SVWSLYAFSA-N endosulfan Chemical compound C([C@@H]12)OS(=O)OC[C@@H]1[C@]1(Cl)C(Cl)=C(Cl)[C@@]2(Cl)C1(Cl)Cl RDYMFSUJUZBWLH-SVWSLYAFSA-N 0.000 claims description 6
- NBEMQPLNBYYUAZ-UHFFFAOYSA-N ethyl acetate;propan-2-one Chemical compound CC(C)=O.CCOC(C)=O NBEMQPLNBYYUAZ-UHFFFAOYSA-N 0.000 claims description 6
- NYPJDWWKZLNGGM-UHFFFAOYSA-N fenvalerate Chemical compound C=1C=C(Cl)C=CC=1C(C(C)C)C(=O)OC(C#N)C(C=1)=CC=CC=1OC1=CC=CC=C1 NYPJDWWKZLNGGM-UHFFFAOYSA-N 0.000 claims description 6
- 238000005259 measurement Methods 0.000 claims description 6
- 239000011259 mixed solution Substances 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 229960000490 permethrin Drugs 0.000 claims description 6
- RLLPVAHGXHCWKJ-UHFFFAOYSA-N permethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 RLLPVAHGXHCWKJ-UHFFFAOYSA-N 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 6
- 239000005874 Bifenthrin Substances 0.000 claims description 5
- 239000005747 Chlorothalonil Substances 0.000 claims description 5
- 239000005591 Pendimethalin Substances 0.000 claims description 5
- OMFRMAHOUUJSGP-IRHGGOMRSA-N bifenthrin Chemical compound C1=CC=C(C=2C=CC=CC=2)C(C)=C1COC(=O)[C@@H]1[C@H](\C=C(/Cl)C(F)(F)F)C1(C)C OMFRMAHOUUJSGP-IRHGGOMRSA-N 0.000 claims description 5
- CRQQGFGUEAVUIL-UHFFFAOYSA-N chlorothalonil Chemical compound ClC1=C(Cl)C(C#N)=C(Cl)C(C#N)=C1Cl CRQQGFGUEAVUIL-UHFFFAOYSA-N 0.000 claims description 5
- DFBKLUNHFCTMDC-PICURKEMSA-N dieldrin Chemical compound C([C@H]1[C@H]2[C@@]3(Cl)C(Cl)=C([C@]([C@H]22)(Cl)C3(Cl)Cl)Cl)[C@H]2[C@@H]2[C@H]1O2 DFBKLUNHFCTMDC-PICURKEMSA-N 0.000 claims description 5
- 229950006824 dieldrin Drugs 0.000 claims description 5
- NGPMUTDCEIKKFM-UHFFFAOYSA-N dieldrin Natural products CC1=C(Cl)C2(Cl)C3C4CC(C5OC45)C3C1(Cl)C2(Cl)Cl NGPMUTDCEIKKFM-UHFFFAOYSA-N 0.000 claims description 5
- RIZMRRKBZQXFOY-UHFFFAOYSA-N ethion Chemical compound CCOP(=S)(OCC)SCSP(=S)(OCC)OCC RIZMRRKBZQXFOY-UHFFFAOYSA-N 0.000 claims description 5
- 239000000945 filler Substances 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- CHIFOSRWCNZCFN-UHFFFAOYSA-N pendimethalin Chemical compound CCC(CC)NC1=C([N+]([O-])=O)C=C(C)C(C)=C1[N+]([O-])=O CHIFOSRWCNZCFN-UHFFFAOYSA-N 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 4
- 239000005944 Chlorpyrifos Substances 0.000 claims description 4
- NOTFZGFABLVTIG-UHFFFAOYSA-N Cyclohexylethyl acetate Chemical compound CC(=O)OCCC1CCCCC1 NOTFZGFABLVTIG-UHFFFAOYSA-N 0.000 claims description 4
- 239000005924 Pirimiphos-methyl Substances 0.000 claims description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 4
- SBPBAQFWLVIOKP-UHFFFAOYSA-N chlorpyrifos Chemical compound CCOP(=S)(OCC)OC1=NC(Cl)=C(Cl)C=C1Cl SBPBAQFWLVIOKP-UHFFFAOYSA-N 0.000 claims description 4
- ZXFXBSWRVIQKOD-UOFFAGTMSA-N epoxyheptachlor Chemical compound ClC1=C(Cl)[C@@]2(Cl)[C@H]3[C@@H]4O[C@@H]4[C@H](Cl)[C@H]3[C@]1(Cl)C2(Cl)Cl ZXFXBSWRVIQKOD-UOFFAGTMSA-N 0.000 claims description 4
- CKAPSXZOOQJIBF-UHFFFAOYSA-N hexachlorobenzene Chemical compound ClC1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl CKAPSXZOOQJIBF-UHFFFAOYSA-N 0.000 claims description 4
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 4
- 238000004949 mass spectrometry Methods 0.000 claims description 4
- 239000002245 particle Substances 0.000 claims description 4
- QHOQHJPRIBSPCY-UHFFFAOYSA-N pirimiphos-methyl Chemical group CCN(CC)C1=NC(C)=CC(OP(=S)(OC)OC)=N1 QHOQHJPRIBSPCY-UHFFFAOYSA-N 0.000 claims description 4
- 239000012488 sample solution Substances 0.000 claims description 4
- 239000011780 sodium chloride Substances 0.000 claims description 4
- LDVVMCZRFWMZSG-OLQVQODUSA-N (3ar,7as)-2-(trichloromethylsulfanyl)-3a,4,7,7a-tetrahydroisoindole-1,3-dione Chemical compound C1C=CC[C@H]2C(=O)N(SC(Cl)(Cl)Cl)C(=O)[C@H]21 LDVVMCZRFWMZSG-OLQVQODUSA-N 0.000 claims description 3
- WURBVZBTWMNKQT-UHFFFAOYSA-N 1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butan-2-one Chemical compound C1=NC=NN1C(C(=O)C(C)(C)C)OC1=CC=C(Cl)C=C1 WURBVZBTWMNKQT-UHFFFAOYSA-N 0.000 claims description 3
- XJFIKRXIJXAJGH-UHFFFAOYSA-N 5-chloro-1,3-dihydroimidazo[4,5-b]pyridin-2-one Chemical group ClC1=CC=C2NC(=O)NC2=N1 XJFIKRXIJXAJGH-UHFFFAOYSA-N 0.000 claims description 3
- 239000005745 Captan Substances 0.000 claims description 3
- 239000005945 Chlorpyrifos-methyl Substances 0.000 claims description 3
- 239000005946 Cypermethrin Substances 0.000 claims description 3
- 239000005892 Deltamethrin Substances 0.000 claims description 3
- 239000005947 Dimethoate Substances 0.000 claims description 3
- 239000005867 Iprodione Substances 0.000 claims description 3
- 239000005949 Malathion Substances 0.000 claims description 3
- 239000005807 Metalaxyl Substances 0.000 claims description 3
- YASYVMFAVPKPKE-UHFFFAOYSA-N acephate Chemical compound COP(=O)(SC)NC(C)=O YASYVMFAVPKPKE-UHFFFAOYSA-N 0.000 claims description 3
- 229910021529 ammonia Inorganic materials 0.000 claims description 3
- 239000011324 bead Substances 0.000 claims description 3
- 238000007664 blowing Methods 0.000 claims description 3
- 229940117949 captan Drugs 0.000 claims description 3
- 239000012159 carrier gas Substances 0.000 claims description 3
- BIWJNBZANLAXMG-IDTQJTQFSA-N cis-chlordane Chemical compound ClC1=C(Cl)[C@@]2(Cl)[C@@H]3C[C@@H](Cl)[C@@H](Cl)[C@@H]3[C@]1(Cl)C2(Cl)Cl BIWJNBZANLAXMG-IDTQJTQFSA-N 0.000 claims description 3
- ZXQYGBMAQZUVMI-UNOMPAQXSA-N cyhalothrin Chemical compound CC1(C)C(\C=C(/Cl)C(F)(F)F)C1C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 ZXQYGBMAQZUVMI-UNOMPAQXSA-N 0.000 claims description 3
- 229960005424 cypermethrin Drugs 0.000 claims description 3
- KAATUXNTWXVJKI-UHFFFAOYSA-N cypermethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 KAATUXNTWXVJKI-UHFFFAOYSA-N 0.000 claims description 3
- 229960002483 decamethrin Drugs 0.000 claims description 3
- OWZREIFADZCYQD-NSHGMRRFSA-N deltamethrin Chemical compound CC1(C)[C@@H](C=C(Br)Br)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 OWZREIFADZCYQD-NSHGMRRFSA-N 0.000 claims description 3
- FHIVAFMUCKRCQO-UHFFFAOYSA-N diazinon Chemical compound CCOP(=S)(OCC)OC1=CC(C)=NC(C(C)C)=N1 FHIVAFMUCKRCQO-UHFFFAOYSA-N 0.000 claims description 3
- OEBRKCOSUFCWJD-UHFFFAOYSA-N dichlorvos Chemical compound COP(=O)(OC)OC=C(Cl)Cl OEBRKCOSUFCWJD-UHFFFAOYSA-N 0.000 claims description 3
- 229950001327 dichlorvos Drugs 0.000 claims description 3
- JXSJBGJIGXNWCI-UHFFFAOYSA-N diethyl 2-[(dimethoxyphosphorothioyl)thio]succinate Chemical compound CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC JXSJBGJIGXNWCI-UHFFFAOYSA-N 0.000 claims description 3
- MCWXGJITAZMZEV-UHFFFAOYSA-N dimethoate Chemical compound CNC(=O)CSP(=S)(OC)OC MCWXGJITAZMZEV-UHFFFAOYSA-N 0.000 claims description 3
- 239000003480 eluent Substances 0.000 claims description 3
- ZNOLGFHPUIJIMJ-UHFFFAOYSA-N fenitrothion Chemical compound COP(=S)(OC)OC1=CC=C([N+]([O-])=O)C(C)=C1 ZNOLGFHPUIJIMJ-UHFFFAOYSA-N 0.000 claims description 3
- XQUXKZZNEFRCAW-UHFFFAOYSA-N fenpropathrin Chemical compound CC1(C)C(C)(C)C1C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 XQUXKZZNEFRCAW-UHFFFAOYSA-N 0.000 claims description 3
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 claims description 3
- 239000010439 graphite Substances 0.000 claims description 3
- 229910002804 graphite Inorganic materials 0.000 claims description 3
- 239000001307 helium Substances 0.000 claims description 3
- 229910052734 helium Inorganic materials 0.000 claims description 3
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 claims description 3
- 150000002500 ions Chemical class 0.000 claims description 3
- ONUFESLQCSAYKA-UHFFFAOYSA-N iprodione Chemical compound O=C1N(C(=O)NC(C)C)CC(=O)N1C1=CC(Cl)=CC(Cl)=C1 ONUFESLQCSAYKA-UHFFFAOYSA-N 0.000 claims description 3
- 229960000453 malathion Drugs 0.000 claims description 3
- NNKVPIKMPCQWCG-UHFFFAOYSA-N methamidophos Chemical compound COP(N)(=O)SC NNKVPIKMPCQWCG-UHFFFAOYSA-N 0.000 claims description 3
- ZQEIXNIJLIKNTD-UHFFFAOYSA-N methyl N-(2,6-dimethylphenyl)-N-(methoxyacetyl)alaninate Chemical compound COCC(=O)N(C(C)C(=O)OC)C1=C(C)C=CC=C1C ZQEIXNIJLIKNTD-UHFFFAOYSA-N 0.000 claims description 3
- KRTSDMXIXPKRQR-AATRIKPKSA-N monocrotophos Chemical compound CNC(=O)\C=C(/C)OP(=O)(OC)OC KRTSDMXIXPKRQR-AATRIKPKSA-N 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 238000002414 normal-phase solid-phase extraction Methods 0.000 claims description 3
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 claims description 3
- PZXOQEXFMJCDPG-UHFFFAOYSA-N omethoate Chemical compound CNC(=O)CSP(=O)(OC)OC PZXOQEXFMJCDPG-UHFFFAOYSA-N 0.000 claims description 3
- 238000012545 processing Methods 0.000 claims description 3
- 239000010453 quartz Substances 0.000 claims description 3
- 239000000377 silicon dioxide Substances 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- XQTLDIFVVHJORV-UHFFFAOYSA-N tecnazene Chemical compound [O-][N+](=O)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl XQTLDIFVVHJORV-UHFFFAOYSA-N 0.000 claims description 3
- BIWJNBZANLAXMG-OESJLNMISA-N trans-chlordane Chemical compound ClC1=C(Cl)[C@@]2(Cl)[C@@H]3C[C@H](Cl)[C@@H](Cl)[C@@H]3[C@]1(Cl)C2(Cl)Cl BIWJNBZANLAXMG-OESJLNMISA-N 0.000 claims description 3
- QOAKBYVRBDPKLD-UHFFFAOYSA-N 1,2,3,4,5-pentachloro-6-(2,3,4,5,6-pentachlorophenyl)sulfanylbenzene Chemical compound ClC1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1SC1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl QOAKBYVRBDPKLD-UHFFFAOYSA-N 0.000 claims description 2
- JLYXXMFPNIAWKQ-SHFUYGGZSA-N alpha-hexachlorocyclohexane Chemical compound Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H](Cl)[C@H]1Cl JLYXXMFPNIAWKQ-SHFUYGGZSA-N 0.000 claims description 2
- JLYXXMFPNIAWKQ-CDRYSYESSA-N beta-hexachlorocyclohexane Chemical compound Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@H](Cl)[C@@H](Cl)[C@@H]1Cl JLYXXMFPNIAWKQ-CDRYSYESSA-N 0.000 claims description 2
- 238000004587 chromatography analysis Methods 0.000 claims description 2
- DFBKLUNHFCTMDC-GKRDHZSOSA-N endrin Chemical compound C([C@@H]1[C@H]2[C@@]3(Cl)C(Cl)=C([C@]([C@H]22)(Cl)C3(Cl)Cl)Cl)[C@@H]2[C@H]2[C@@H]1O2 DFBKLUNHFCTMDC-GKRDHZSOSA-N 0.000 claims description 2
- JLYXXMFPNIAWKQ-GNIYUCBRSA-N gamma-hexachlorocyclohexane Chemical compound Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl JLYXXMFPNIAWKQ-GNIYUCBRSA-N 0.000 claims description 2
- JLYXXMFPNIAWKQ-UHFFFAOYSA-N gamma-hexachlorocyclohexane Natural products ClC1C(Cl)C(Cl)C(Cl)C(Cl)C1Cl JLYXXMFPNIAWKQ-UHFFFAOYSA-N 0.000 claims description 2
- FRCCEHPWNOQAEU-UHFFFAOYSA-N heptachlor Chemical compound ClC1=C(Cl)C2(Cl)C3C=CC(Cl)C3C1(Cl)C2(Cl)Cl FRCCEHPWNOQAEU-UHFFFAOYSA-N 0.000 claims description 2
- 239000012535 impurity Substances 0.000 claims description 2
- MEBQXILRKZHVCX-UHFFFAOYSA-N methidathion Chemical compound COC1=NN(CSP(=S)(OC)OC)C(=O)S1 MEBQXILRKZHVCX-UHFFFAOYSA-N 0.000 claims description 2
- LKPLKUMXSAEKID-UHFFFAOYSA-N pentachloronitrobenzene Chemical compound [O-][N+](=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl LKPLKUMXSAEKID-UHFFFAOYSA-N 0.000 claims description 2
- KVGLBTYUCJYMND-UHFFFAOYSA-N fonofos Chemical compound CCOP(=S)(CC)SC1=CC=CC=C1 KVGLBTYUCJYMND-UHFFFAOYSA-N 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 7
- 238000003908 quality control method Methods 0.000 abstract description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 4
- 239000012086 standard solution Substances 0.000 description 4
- 241000510654 Bupleurum chinense Species 0.000 description 3
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 235000013311 vegetables Nutrition 0.000 description 3
- 208000015817 Infant Nutrition disease Diseases 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- FFSJPOPLSWBGQY-UHFFFAOYSA-N triazol-4-one Chemical compound O=C1C=NN=N1 FFSJPOPLSWBGQY-UHFFFAOYSA-N 0.000 description 2
- IAKOZHOLGAGEJT-UHFFFAOYSA-N 1,1,1-trichloro-2,2-bis(p-methoxyphenyl)-Ethane Chemical compound C1=CC(OC)=CC=C1C(C(Cl)(Cl)Cl)C1=CC=C(OC)C=C1 IAKOZHOLGAGEJT-UHFFFAOYSA-N 0.000 description 1
- LGZZJTIUEJNNKV-UHFFFAOYSA-N 1,2,3,4,5-pentachloro-6-methylsulfanylbenzene Chemical compound CSC1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl LGZZJTIUEJNNKV-UHFFFAOYSA-N 0.000 description 1
- 244000236521 Bupleurum rotundifolium Species 0.000 description 1
- 235000015221 Bupleurum rotundifolium Nutrition 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- UHZJCOPSHXCQCX-UHFFFAOYSA-N ClC1(C(C(C(C(N(Cl)Cl)(C1Cl)Cl)(Cl)Cl)(Cl)Cl)(Cl)Cl)Cl Chemical compound ClC1(C(C(C(C(N(Cl)Cl)(C1Cl)Cl)(Cl)Cl)(Cl)Cl)(Cl)Cl)Cl UHZJCOPSHXCQCX-UHFFFAOYSA-N 0.000 description 1
- YVGGHNCTFXOJCH-UHFFFAOYSA-N DDT Chemical compound C1=CC(Cl)=CC=C1C(C(Cl)(Cl)Cl)C1=CC=C(Cl)C=C1 YVGGHNCTFXOJCH-UHFFFAOYSA-N 0.000 description 1
- 240000003421 Dianthus chinensis Species 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- PNVJTZOFSHSLTO-UHFFFAOYSA-N Fenthion Chemical compound COP(=S)(OC)OC1=CC=C(SC)C(C)=C1 PNVJTZOFSHSLTO-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- CWFOCCVIPCEQCK-UHFFFAOYSA-N chlorfenapyr Chemical compound BrC1=C(C(F)(F)F)N(COCC)C(C=2C=CC(Cl)=CC=2)=C1C#N CWFOCCVIPCEQCK-UHFFFAOYSA-N 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- DOFZAZXDOSGAJZ-UHFFFAOYSA-N disulfoton Chemical compound CCOP(=S)(OCC)SCCSCC DOFZAZXDOSGAJZ-UHFFFAOYSA-N 0.000 description 1
- 238000003255 drug test Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000010794 food waste Substances 0.000 description 1
- 238000002546 full scan Methods 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000002728 pyrethroid Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229930192014 saikosaponin Natural products 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Landscapes
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Abstract
The invention belongs to the field of traditional Chinese medicine quality detection and relates to a radix bupleuri medicinal material detection method. The radix bupleuri medicinal material detection method comprises determining saikosides a and d in radix bupleuri and determining pesticide residue content of the radix bupleuri medicinal material. The radix bupleuri medicinal material detection method solves the technical problem of operation complexity, limitation and difficult quality control of the traditional physicochemical property discriminating method, has high accuracy, can be operated simply, has a low cost and has a good application prospect and economic benefits.
Description
Technical Field
The invention belongs to the field of quality detection of traditional Chinese medicinal materials, and particularly relates to a quality detection method of a radix bupleuri medicinal material.
Background
The bupleurum is a traditional Chinese medicine prepared by processing dried roots of the dianthus chinensis, is sweet in taste and slightly warm in nature, has the effects of entering liver and stomach channels, clearing deficiency heat, removing infantile malnutrition heat and the like, and is clinically used for treating yin deficiency fever, bone steaming fatigue heat, infantile malnutrition heat and other diseases. The bupleurum medicinal material has been on the market in China for many years, and the clinical effect is widely determined. The bupleuri radix contains multiple chemical components, mainly including saikosaponin (four kinds of saikosaponin a, b, c, d), sterol, volatile oil, fatty acid and polysaccharide, etc. Modern researches show that the components contained in bupleurum have wide physiological activity, wherein the contents of saikosaponin a and saikosaponin d are closely related to the antipyretic and anti-inflammatory effects of bupleurum, so that the contents of the saikosaponin a and saikosaponin d are often used as important indexes for controlling the quality of bupleurum medicinal materials.
In recent years, the market demand of bupleurum is continuously increased, wild resources are reduced year by year, and the development of artificial cultivation is slow, so that the storage amount and the yield of bupleurum resources are greatly reduced. Leading to the appearance of a plurality of counterfeit products in the market, wherein the pesticide residue of a plurality of counterfeit products exceeds the standard and explodes the table, bringing great impact to the quality, the medication safety and the effectiveness of the bupleurum medicinal materials, and becoming the bottleneck restricting the development of bupleurum series medicinal materials.
At present, the effective detection method of the quality bupleurum is the traditional identification method of morphological characteristics and physicochemical characteristics, has certain limitation, is not enough to control the quality of the bupleurum on the whole, and as a clinical common traditional Chinese medicine, the truth and the falseness of the bupleurum are influenced by a plurality of factors such as physicochemical indexes, large pesticide residue and the like, so a scientific quality detection method is necessary to be established for evaluating the quality of the bupleurum.
Disclosure of Invention
Therefore, the technical problem to be solved by the invention is to solve the problems of complex detection method and difficult quality control of the bupleurum medicinal material in the prior art, and further provide a method for simply and quickly detecting the bupleurum medicinal material with high accuracy.
In order to solve the technical problems, the invention is realized by the following technical scheme:
the invention provides a method for detecting bupleurum medicinal materials, which comprises the following steps of measuring the content of saikosaponin a and saikosaponin d and measuring the pesticide residue, wherein the method comprises the following steps of:
a method for detecting bupleurum medicinal material is characterized in that the method comprises the following steps of measuring the total amount of saikosaponin a and saikosaponin d and measuring the pesticide residue, wherein,
a: the method for measuring the total amount of the saikosaponin a and the saikosaponin d comprises the following steps:
(1) accurately weighing reference substances of picroside a and picroside d, and adding methanol to prepare a solution containing 0.4mg of picroside a and 0.5mg of picroside dL in each 1mL, namely the reference solution;
(2) accurately weighing 0.5g of bupleuri radix powder to be measured, adding 25mL of methanol solution containing 5% concentrated ammonia reagent, performing ultrasonic treatment at 30 deg.C, filtering, washing container and residue with 20mL of methanol for 2 times, mixing washing solution and filtrate, and recovering solvent to dry; dissolving the residue with methanol, diluting to 5mL, filtering, and collecting the filtrate to obtain sample solution;
(3) according to the high performance liquid chromatography, octadecylsilane chemically bonded silica is used as a filler, acetonitrile is used as a mobile phase A, water is used as a mobile phase B, and gradient elution is carried out according to the following procedures: from 0-50min, mobile phase a: the volume ratio of the mobile phase B is from 25%: 75% → 90%: 10 percent; from 50-55min, mobile phase a: the volume ratio of the mobile phase B is 90%: 10 percent; the detection wavelength is 210 nm; the theoretical plate number is not less than 10000 calculated according to the peak of saikosaponin a;
respectively and precisely weighing 20 μ l of reference solution and 10-20 μ l of test solution, injecting into liquid chromatograph, and measuring;
b: the determination of the pesticide residue comprises the following steps:
(1) accurately weighing a proper amount of triphenyl phosphate, and adding acetone to prepare a solution containing 100 mu g of triphenyl phosphate per 1ml as an internal standard stock solution;
precisely measuring 1ml of each pesticide reference product storage solution and 1ml of the internal standard storage solution respectively, and adding acetone to a constant volume of 100ml to serve as a mixed reference product storage solution; precisely measuring appropriate amount, adding acetonitrile to constant volume to obtain 20-1000ng/ml solutions with different concentrations, and using as mixed reference solution;
dissolving appropriate amount of ribonolactone in acetonitrile to obtain a solution containing 20mg of ribonolactone per 1ml, dissolving appropriate amount of sorbitol in water to obtain a solution containing 10mg of sorbitol per 1 ml; precisely measuring the ribonolactone and sorbitol solution respectively by 1ml, mixing uniformly, adding acetonitrile to constant volume to 10ml, and using the mixture as an analysis protective agent;
(2) precisely weighing 10g of medicinal material fine powder to be measured, adding 1g of sodium chloride, uniformly mixing, precisely adding 100ml of acetone, carrying out ice bath ultrasonic treatment for 30 minutes, centrifuging, quickly transferring supernatant into a conical bottle with a plug containing 1g of anhydrous sodium sulfate, and standing for 30 minutes; then, precisely measuring 60ml of the solution, concentrating the solution under reduced pressure to be nearly dry, and adding a solvent with the volume ratio of 1:1, dissolving a sample in cyclohexane-ethyl acetate solution, fixing the volume to 10ml, filtering, taking filtrate, purifying by GPC gel permeation chromatography, and performing gel permeation chromatography on the filtrate in a volume ratio of 1: eluting with cyclohexane-ethyl acetate solution of 1 as mobile phase, collecting eluate, transferring into KD bottle, and concentrating under reduced pressure to near dryness;
adding the mixture into the sample in a volume ratio of 1: dissolving 5ml of the ethyl acetate-acetone mixed solution of 1, transferring the dissolved solution to a graphite carbon-amino mixed solid phase extraction column, and mixing the dissolved solution with the volume ratio of 1: eluting with 15ml of ethyl acetate-acetone mixed solution of 1, collecting eluent, blowing nitrogen to near dryness, adding 5 mu l of internal standard stock solution, adding acetonitrile to constant volume to 1ml, and using the volume as a test solution;
(3) precisely measuring 400 mu L of each of the mixed reference substance solution and the test substance solution with each concentration, respectively adding 100 mu L of the analysis protective agent, uniformly mixing, precisely absorbing 1 mu L of the analysis protective agent, and performing gas chromatography-mass spectrometry combined instrument measurement; wherein,
the gas chromatographic analysis conditions are as follows: taking an elastic quartz capillary column DB17ms with the specification of 30m multiplied by 0.25mm multiplied by 0.25um, taking high-purity helium as a carrier gas, the column flow rate is 1.3ml/min, the sample injection amount is 1 mu l, adopting high-pressure non-split-flow sample injection, setting the temperature of a sample injection port to be 230 ℃, and specifically adopting a temperature rise program as follows: the initial temperature was 60 ℃, ramped to 120 ℃ at 30 ℃/min, ramped to 200 ℃ at 10 ℃/min, ramped to 230 ℃ at 2 ℃/min, ramped to 300 ℃ at 30 ℃/min, and held for 7 minutes;
further, the EI source mass spectrometry conditions are as follows: the electron energy is set to 70eV, the ion source temperature is 230 ℃, and the interface temperature is 250 ℃.
In the determination of the pesticide residue, the GPC gel permeation chromatography purification step specifically comprises the following conditions: the filler is Bio-Beads S-X3200-400 mesh, the purification column is 2.5mm multiplied by 40cm, the specific elution parameters are purification and impurity removal 900S, the target is collected for 1200S, and the column is cleaned for 300S.
Further, in the measurement of the pesticide residue, the pesticide reference substance comprises dichlorvos, methamidophos, acephate, tetrachloronitrobenzene, hexachlorobenzene, alpha-hexachlorocyclohexane, beta-hexachlorocyclohexane, gamma-hexachlorocyclohexane, omethoate, diazinon, pentachlorophenyl, monocrotophos, disulfoton, phosphamidol I, dimethoate, heptachlor, pentachloroaniline, chlorothalonil, chlorpyrifos-methyl, aldrin, captan, phosphamidol II, methyl parathion, methyl pyrimidylphenyl sulfide, methyl pentachlorophenyl sulfide, metalaxyl, triadimefon, chlorpyrifos, malathion, fenitrothion, parathion, pendimethalin, cis epoxy heptachlor, trans epoxy heptachlor, triadimenol A, triadimenol B, trans chlordane, cis endosulfan, cis chlordane, trans endosulfan, PP ' -DDE, PP ' -DDD, DDT ' -DDT, PP' -DDT, dieldrin, methidathion, endrin, ethion, triphenyl phosphate, bifenthrin, endosulfan, iprodione, fenpropathrin, dicofol, cyhalothrin, methoxyDDT, dicofol, vothiofos, permethrin 1, permethrin 2, cypermethrin, fenvalerate, deltamethrin.
In the step A, in the content determination of the saikosaponin a and the saikosaponin d, the particle size of the medicinal material to be determined is 180-.
Furthermore, in the step B, in the determination of the pesticide residue, the particle size of the to-be-detected medicinal material is 180-.
In the step of measuring the total amount of the saikosaponin a and the saikosaponin d, the conditions of the step of ultrasonic treatment are as follows: the power is 200W, the frequency is 40KHz, and the ultrasonic treatment is carried out for 30 min.
The method of the invention determines the authenticity of the bupleurum medicinal material by measuring the content of saikosaponin a and saikosaponin d contained in the bupleurum medicinal material and detecting the pesticide residue of the bupleurum medicinal material. And the content of the saikosaponin a and the content of the saikosaponin d are determined by high performance liquid chromatography, and the method is not only accurate, but also simple and easy to implement. The method detects the residual pesticide amount of the medicinal materials in a gas chromatography-mass spectrometry combined mode, has high detection accuracy and simple and quick method, can effectively detect common pesticide types in the bupleurum medicinal materials at one time through specific screening of detection conditions, and has better accuracy and practical effect.
Drawings
In order that the present disclosure may be more readily and clearly understood, the following detailed description of the present disclosure is provided in connection with specific examples thereof and with the accompanying drawings, in which:
FIG. 1 is a chart of a bupleuri radix mixed control in example 1 of the present invention;
FIG. 2 is a chart of a sample of bupleuri radix according to example 1 of the present invention;
FIG. 3 is a full scan gas chromatogram of a pesticide standard in example 2 of the present invention;
FIG. 4 is a 0-10 minute scanning gas chromatogram of the pesticide standard in example 2 of the present invention;
FIG. 5 is a 10-20 minute scanning gas chromatogram of the pesticide standard in example 2 of the present invention;
FIG. 6 is a 20-40 minute scanning gas chromatogram of the pesticide standard in example 2 of the present invention.
Detailed Description
Example 1 determination of the Total amount of saikosaponin a, d in Bupleurum chinense
1 Instrument and reagent
1.1 instruments
Shimadzu LC20-AT liquid chromatograph;
waters2695-2998 liquid chromatograph;
ultrasonic cleaner (250W, 40 kHz).
1.2 reagents
Methanol, acetonitrile (chromatically pure), drochen distilled water;
the saikosaponin a (110777-.
1.3 samples of medicinal materials
Collecting Bupleurum samples from different places in Gansu province, wherein the test medicinal material production places are respectively selected from: gansu Xixi county, Gansu Linxia county, Gansu Zhang county, Gansu Li county, Gansu Xiong county in 2 batches (respectively marked as 1-2), Gansu Lingshi county, Gansu Zhang county, Gansu Wudu district Anhua town, Gansu Taishan county, Gansu Ping Shuliang city mountain Kongtong district, Gansu Wushan county in 2 batches (respectively marked as 1-2), Gansu Xixi county Yunnan town, Gansu Xiong county Tong Yiyi town in 3 batches (respectively marked as 1-3). The identification result of each test drug is Bupleurum chinense DC.
2. Method of producing a composite material
Accurately weighing picroside a and picroside d reference substances, and adding methanol to prepare a solution containing 0.4mg of picroside a and 0.5mg of picroside d per 1mL, namely the reference substance solution;
accurately weighing 0.5g of bupleuri radix powder to be measured, adding 25mL of methanol solution containing 5% concentrated ammonia reagent, performing ultrasonic treatment at 30 deg.C, filtering, washing container and residue with 20mL of methanol for 2 times, mixing washing solution and filtrate, and recovering solvent to dry; dissolving the residue with methanol, diluting to 5mL, filtering, and collecting the filtrate to obtain sample solution;
according to the high performance liquid chromatography, octadecylsilane chemically bonded silica is used as a filler, acetonitrile is used as a mobile phase A, water is used as a mobile phase B, and gradient elution is carried out according to the following procedures: from 0-50min, mobile phase a: the volume ratio of the mobile phase B is from 25%: 75% → 90%: 10 percent; from 50-55min, mobile phase a: the volume ratio of the mobile phase B is 90%: 10 percent; the detection wavelength is 210 nm; the theoretical plate number is not less than 10000 calculated according to the peak of saikosaponin a;
respectively and precisely weighing 20 μ l of reference solution and 10-20 μ l of test solution, injecting into liquid chromatograph, and measuring;
3. results
The chromatogram of 19 batches of test drugs is shown in figures 1 and 2, and the detection results are shown in table 1 below.
TABLE 1 Collection and assay of Bupleurum samples (%)
Example 2 determination of amount of pesticide residue in Bupleurum chinense
1 Instrument and reagent
1.1 instruments
Clarus600 gas chromatography-mass spectrometer (PE company, USA), HS10260D ultrasonic extractor (Kunshan ultrasonic instrument Co., Ltd.), RE-52A rotary evaporator (Shanghai Yangrong Biochemical instruments factory).
1.2 reagent
Dichlorvos, methamidophos, acephate, tetrachloronitrobenzene, hexachlorobenzene, alpha-hexachlorohexa, beta-hexachlorohexa, gamma-hexachlorohexa, omethoate, diazinon, pentachloronitrobenzene, monocrotophos, chlorfenapyr, phosphamidol I, dimethoate, heptachlor, pentachloranil, chlorothalonil, chlorpyrifos-methyl, aldrin, captan, phosphamidol II, methyl parathion, pirimiphos-methyl, pentachlorophenyl sulfide, metalaxyl, triadimefon, chlorpyrifos, malathion, fenitrothion, parathion, pendimethalin, cis-epoxy heptachlor, trans-epoxy heptachlor, triadimenol A, triadimenol B, trans-chlordane, cis-chlordane, trans-endosulfan, PP '-DDD, PP' -DDT, Dietschafos, ethion, thion, chlorpyrifos, chlorp, 64 kinds of pesticide reference substance storage solutions such as triphenyl phosphate, bifenthrin, endosulfan, iprodione, fenpropathrin, dicofol, cyhalothrin, methoxy DDT, trichlorfone, fenthion, permethrin 1, permethrin 2, cypermethrin, fenvalerate, deltamethrin and the like are provided by China food and drug testing institute.
Triphenyl phosphate, acetone, acetonitrile, cyclohexane and ethyl acetate are imported pesticide residue grade; ribonolactone, sorbitol, sodium chloride and anhydrous sodium sulfate are superior pure.
1.3 samples
The genuine batch samples of radix bupleuri and the like purchased from the production place or the Lanzhou yellow river medicinal material market are all raw medicinal materials, and are numbered and detected according to different batches.
2 methods and results
2.1 preparation of internal standard stock solution and analytical protectant
Accurately weighing proper amount of triphenyl phosphate, and adding acetone to prepare solution containing 100 mu g of acetone per 1 ml.
Preparation of an analytical protective agent: taking a proper amount of ribonolactone, adding acetonitrile to dissolve the ribonolactone, and preparing a solution containing 20mg of ribonolactone per 1 ml; in addition, a proper amount of sorbitol is taken, and water is added for dissolving to prepare a solution containing 10mg of sorbitol per 1 ml. Precisely measuring the ribonolactone and sorbitol solutions by 1ml respectively, adding into the same 10ml measuring flask, diluting with acetonitrile to scale, and shaking.
2.2 preparation of Mixed control solutions
Precisely measuring 1ml of each pesticide reference stock solution and 1ml of internal standard stock solution respectively, placing into a 100ml measuring flask, diluting with acetone to scale, shaking up, and using as a mixed reference stock solution (1 microgram/ml). Accurately weighing appropriate amount, respectively, and adding acetonitrile to obtain 20-1000ng/ml mixed reference solutions of different concentration series.
2.3 preparation of test solutions
Precisely weighing 10g of each batch of test sample fine powder, placing the fine powder in a 100ml conical flask, adding 1g of sodium chloride, precisely adding 100ml of acetone, carrying out ultrasonic treatment in ice bath for 30 minutes, centrifuging, quickly transferring supernatant into the conical flask with the plug containing 1g of anhydrous sodium sulfate, and standing for 30 minutes. Precisely measuring 60ml, concentrating under reduced pressure to near dryness, adding a small amount of cyclohexane: dissolving a sample with ethyl acetate (1:1) solution, quantitatively diluting to 10ml, mixing uniformly, filtering, purifying the filtrate by Gel Permeation Chromatography (GPC), injecting 5ml, (GPC main parameters: packing Bio-Beads S-X3200-400 meshes, purifying column 2.5mm × 40cm, elution parameters: pre run 900S, main run 1200S, tail run 300S), purifying with cyclohexane: eluting with ethyl acetate (1:1) as mobile phase, collecting eluate, transferring into KD bottle, and concentrating under reduced pressure to near dryness.
2.4 purification of the sample solution
Adding 5ml of ethyl acetate-acetone (1:1) mixed solution for dissolving, quantitatively transferring the dissolved solution to a graphite carbon (500mg) -amino (500mg) mixed solid phase extraction column, eluting the column with 15ml of ethyl acetate-acetone (1:1) mixed solution, collecting eluent, blowing nitrogen to the near-dry state, adding acetonitrile into residues for dissolving, adding 5 mu l of internal standard stock solution, and fixing the volume of the acetonitrile to 1ml to obtain the product.
2.5 gas-mass spectrometry
Gas chromatography analysis conditions elastic quartz capillary column (30m × 0.25mm × 0.25um) DB17ms, carrier gas is high-purity helium, and column flow rate is 1.3 ml/min; the injection port temperature is 230 ℃, the injection amount is 1 mu l, and high-pressure non-split injection is carried out.
Specific temperature rise procedures are as follows: the initial temperature is 60 deg.C, 30 deg.C/min to 120 deg.C, 10 deg.C/min to 200 deg.C, 2 deg.C/min to 230 deg.C, 30 deg.C/min to 300 deg.C, and is maintained for 7 min.
Mass spectrometry (EI source) measurement conditions: 70eV, the ion source temperature 230 ℃ and the interface temperature 250 ℃.
The SIM conditions of each sample to be tested are shown in Table 3, and the full-scan gas chromatogram and the 0-10 min, 10-20 min and 20-40 min scan gas chromatograms of each pesticide standard are respectively shown in figures 3, 4, 5 and 6.
TABLE 3GC-MS detection index and SIM determination conditions
2.6 methodological validation
2.6.1 precision test
The diluted mixed standard solution was precisely aspirated by 1. mu.L, and the sample injection was repeated 5 times to calculate the RSD value, as shown in Table 4.
Precision test of 464 pesticides in table
2.6.2 sample recovery test
Adding certain mixed standard solution into the samples respectively to form 3 samples with 3 addition levels, extracting and breaking loose and detecting according to a selected method, and calculating the recovery rate of various pesticides in the samples by deducting the background, wherein the results are shown in Table 5.
Sample application recovery test for 564 pesticides in table
2.6.3 detection Limit determination
The pesticide standard solution was diluted to different concentrations and the minimum amount of components detected was determined, the results are shown in table 6.
TABLE 664 detection limits of pesticides
2.6.4 Linear relationship
The pesticide standard solutions were diluted to different concentrations and the linear range of the components was determined and the results are shown in table 7.
TABLE 764 Linear equations for pesticides
2.7 assay method
Respectively and precisely measuring 400 mu L of each of the mixed reference solution and the test solution, adding 00 mu L of the analysis protective agent, uniformly mixing, respectively and precisely absorbing 1 mu L of the mixture, injecting the mixture into a gas chromatography-mass spectrometer, measuring and calculating to obtain the test solution, wherein the results are shown in Table 8.
TABLE 8 background determination of pesticide residue in bupleuri radix (mg/kg)
3. Measurement results and analysis
3.1 pesticide residue determination results 7 batches of samples all detected pesticide residues, the detection rate was 100%, and the current situation of pesticide residues in radix bupleuri was relatively common. Relates to 14 different pesticides of organic chlorine, organic phosphorus and pyrethroid. The pesticide residue batches include 1 batch of hexachlorobenzene, 1 batch of chlorothalonil, 4 batches of methyl parathion, 1 batch of pirimiphos-methyl, 2 batches of parathion, 3 batches of triazolone, 1 batch of dicofol, 1 batch of pendimethalin, 1 batch of dieldrin, 1 batch of ethion, 1 batch of bifenthrin, 4 batches of methoxyDDT 2 and dicofol.
3.2 the Chinese thorowax root medicinal materials have different pesticide residues, wherein the pesticide residues of 2 varieties are different, and the pesticide residues of 2-3 varieties are different. The causes of pesticide residue in the traditional Chinese medicinal materials are complicated due to the influences of factors such as environment, planting technology, processing and storage.
3.3 in the production of Chinese medicinal material GAP, there are 54 kinds of forbidden pesticides. 4 kinds of forbidden pesticides including parathion, methyl parathion, Dieldrin and DDT are detected from the bupleurum. Other detected pesticides belong to pesticides which can be used in production.
3.4 the maximum residual limit of pesticide in the food is regulated and analyzed by adopting the national standard GB2763-2005, and although detected, the maximum residual limit of pesticide in the food is not exceeded: chlorothalonil, pirimiphos-methyl, dicofol, bifenthrin, pendimethalin, dieldrin and ethion. The food residue standard is exceeded, namely methyl parathion (0.1 mg/kg of grains and 0.02mg/kg of vegetables and fruits) exceeds the standard by 4-10 times; parathion (0.1 mg/kg of grains and 0.01mg/kg of vegetables and fruits) exceeds 2-12 times, triazolone (0.5 mg/kg of paddy and 0.05mg/kg of vegetables) exceeds 1-4 times, and dicofol (2 mg/kg of fruits) exceeds 0.4-0.9 time.
In the general analysis, the pesticide detection rate of the bupleurum samples is 100 percent, the 7 samples have pesticide exceeding standards, and the sample exceeding rate is 100 percent; 4 forbidden pesticides are detected, and the forbidden pesticides in 6 batches of samples exceed the standard, with the standard exceeding rate of 85.7%.
3.5 according to the measurement result, the pesticide prohibited in the production of the traditional Chinese medicine GAP and the pesticide which is allowed to be used but is easy to exceed the standard in the production are recommended to be checked in a limited way. The proposed methyl parathion is not more than 0.1mg/kg, and parathion is not more than 0.1 mg/kg.
It should be understood that the above examples are only for clarity of illustration and are not intended to limit the embodiments. Other variations and modifications will be apparent to persons skilled in the art in light of the above description. And are neither required nor exhaustive of all embodiments. And obvious variations or modifications therefrom are within the scope of the invention.
Claims (6)
1. A method for detecting bupleurum medicinal material is characterized in that the method comprises the following steps of measuring the total amount of saikosaponin a and saikosaponin d and measuring the pesticide residue, wherein,
a: the method for measuring the total amount of the saikosaponin a and the saikosaponin d comprises the following steps:
(1) accurately weighing reference substances of picroside a and picroside d, and adding methanol to prepare a solution containing 0.4mg of picroside a and 0.5mg of picroside dL in each 1mL, namely the reference solution;
(2) accurately weighing 0.5g of bupleuri radix powder to be measured, adding 25mL of methanol solution containing 5% concentrated ammonia reagent, performing ultrasonic treatment at 30 deg.C, filtering, washing container and residue with 20mL of methanol for 2 times, mixing washing solution and filtrate, and recovering solvent to dry; dissolving the residue with methanol, diluting to 5mL, filtering, and collecting the filtrate to obtain sample solution;
(3) according to the high performance liquid chromatography, octadecylsilane chemically bonded silica is used as a filler, acetonitrile is used as a mobile phase A, water is used as a mobile phase B, and gradient elution is carried out according to the following procedures: from 0-50min, mobile phase a: the volume ratio of the mobile phase B is from 25%: 75% → 90%: 10 percent; from 50-55min, mobile phase a: the volume ratio of the mobile phase B is 90%: 10 percent; the detection wavelength is 210 nm; the theoretical plate number is not less than 10000 calculated according to the peak of saikosaponin a;
respectively and precisely weighing 20 μ l of reference solution and 10-20 μ l of test solution, injecting into liquid chromatograph, and measuring;
b: the determination of the pesticide residue comprises the following steps:
(1) accurately weighing a proper amount of triphenyl phosphate, and adding acetone to prepare a solution containing 100 mu g of triphenyl phosphate per 1ml as an internal standard stock solution;
precisely measuring 1ml of each pesticide reference product storage solution and 1ml of the internal standard storage solution respectively, and adding acetone to a constant volume of 100ml to serve as a mixed reference product storage solution; precisely measuring appropriate amount, adding acetonitrile to constant volume to obtain 20-1000ng/ml solutions with different concentrations, and using as mixed reference solution;
dissolving appropriate amount of ribonolactone in acetonitrile to obtain a solution containing 20mg of ribonolactone per 1ml, dissolving appropriate amount of sorbitol in water to obtain a solution containing 10mg of sorbitol per 1 ml; precisely measuring the ribonolactone and sorbitol solution respectively by 1ml, mixing uniformly, adding acetonitrile to constant volume to 10ml, and using the mixture as an analysis protective agent;
(2) precisely weighing 10g of medicinal material fine powder to be measured, adding 1g of sodium chloride, uniformly mixing, precisely adding 100ml of acetone, carrying out ice bath ultrasonic treatment for 30 minutes, centrifuging, quickly transferring supernatant into a conical bottle with a plug containing 1g of anhydrous sodium sulfate, and standing for 30 minutes; then, precisely measuring 60ml of the solution, concentrating the solution under reduced pressure to be nearly dry, and adding a solvent with the volume ratio of 1:1, dissolving a sample in cyclohexane-ethyl acetate solution, fixing the volume to 10ml, filtering, taking filtrate, purifying by GPC gel permeation chromatography, and performing gel permeation chromatography on the filtrate in a volume ratio of 1: eluting with cyclohexane-ethyl acetate solution of 1 as mobile phase, collecting eluate, transferring into KD bottle, and concentrating under reduced pressure to near dryness;
adding the mixture into the sample in a volume ratio of 1: dissolving 5ml of the ethyl acetate-acetone mixed solution of 1, transferring the dissolved solution to a graphite carbon-amino mixed solid phase extraction column, and mixing the dissolved solution with the volume ratio of 1: eluting with 15ml of ethyl acetate-acetone mixed solution of 1, collecting eluent, blowing nitrogen to near dryness, adding 5 mu l of internal standard stock solution, adding acetonitrile to constant volume to 1ml, and using the volume as a test solution;
(3) precisely measuring 400 mu L of each of the mixed reference substance solution and the test substance solution with each concentration, respectively adding 100 mu L of the analysis protective agent, uniformly mixing, precisely absorbing 1 mu L of the analysis protective agent, and performing gas chromatography-mass spectrometry combined instrument measurement; wherein,
the gas chromatographic analysis conditions are as follows: taking an elastic quartz capillary column DB17ms with the specification of 30m multiplied by 0.25mm multiplied by 0.25um, taking high-purity helium as a carrier gas, the column flow rate is 1.3ml/min, the sample injection amount is 1 mu l, adopting high-pressure non-split-flow sample injection, setting the temperature of a sample injection port to be 230 ℃, and specifically adopting a temperature rise program as follows: the initial temperature was 60 ℃, ramped to 120 ℃ at 30 ℃/min, ramped to 200 ℃ at 10 ℃/min, ramped to 230 ℃ at 2 ℃/min, ramped to 300 ℃ at 30 ℃/min, and held for 7 minutes;
the EI source mass spectrometry conditions are as follows: the electron energy is set to 70eV, the ion source temperature is 230 ℃, and the interface temperature is 250 ℃.
2. The method for detecting the bupleurum medicinal material according to claim 1, wherein in the determination of the pesticide residue, the GPC gel permeation chromatography purification step specifically comprises the following conditions: the filler is Bio-Beads S-X3200-400 mesh, the purification column is 2.5mm multiplied by 40cm, the specific elution parameters are purification and impurity removal 900S, the target is collected for 1200S, and the column is cleaned for 300S.
3. The method for detecting the bupleurum medicinal material according to claim 1 or 2, wherein in the determination of the pesticide residue, the pesticide reference substance comprises dichlorvos, methamidophos, acephate, tetrachloronitrobenzene, hexachlorobenzene, alpha-hexachlorocyclohexane, beta-hexachlorocyclohexane, gamma-hexachlorocyclohexane, omethoate, diazinon, quintozene, monocrotophos, fonofos, phosphamidol, dimethoate, heptachlor, pentachloranilide, chlorothalonil, chlorpyrifos-methyl, aldrin, captan, phosphamidol II, methyl parathion, pirimiphos-methyl, pentachlorophenyl sulfide, metalaxyl, triadimefon, chlorpyrifos, malathion, fenitrothion, parathion, pendimethalin, cis epoxy heptachlor, trans epoxy heptachlor, triadimenol A, triadimenol B, trans-chlordane, cis endosulfan, cis chlordane, and, Trans-endosulfan, PP '-DDE, PP' -DDD, OP '-DDT, PP' -DDT, dieldrin, methidathion, endrin, ethion, triphenyl phosphate, bifenthrin, endosulfan, iprodione, fenpropathrin, dicofol, cyhalothrin, methoxyDDT, dicofol, vothiofos, permethrin 1, permethrin 2, cypermethrin, fenvalerate, deltamethrin.
4. The method for detecting bupleurum medicinal material according to any one of claims 1 to 3, wherein the particle size of the medicinal material to be detected is 180-2000 μm in the content determination of the saikosaponin a and d.
5. The method for detecting the bupleurum medicinal material as claimed in any one of claims 1 to 4, wherein the particle size of the medicinal material to be detected in the determination of the pesticide residue is 180-2000 μm.
6. The method for detecting the bupleurum medicinal material according to any one of claims 1 to 5, wherein in the step of measuring the total amount of the saikosaponin a and the saikosaponin d, the conditions of the step of ultrasonic processing are as follows: the power is 200W, the frequency is 40KHz, and the ultrasonic treatment is carried out for 30 min.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410374865.4A CN104267109A (en) | 2014-07-31 | 2014-07-31 | Radix bupleuri medicinal material detection method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410374865.4A CN104267109A (en) | 2014-07-31 | 2014-07-31 | Radix bupleuri medicinal material detection method |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104267109A true CN104267109A (en) | 2015-01-07 |
Family
ID=52158650
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410374865.4A Pending CN104267109A (en) | 2014-07-31 | 2014-07-31 | Radix bupleuri medicinal material detection method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104267109A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104698098A (en) * | 2015-02-12 | 2015-06-10 | 吉林敖东中药饮片股份有限公司 | Bupleurum chinense content determination method |
CN109270258A (en) * | 2018-10-31 | 2019-01-25 | 武汉利恩达医疗科技有限公司 | A kind of saikosaponin D Test paper preparation method |
CN111089913A (en) * | 2019-10-16 | 2020-05-01 | 四川恒通动保生物科技有限公司 | Quality control method of bupleurum chinense injection |
CN113030340A (en) * | 2021-04-09 | 2021-06-25 | 北京市药品检验所 | Method for measuring content of characteristic components of radix bupleuri in radix bupleuri and preparation thereof by liquid phase coupling high-resolution mass spectrometry |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102475871A (en) * | 2010-11-26 | 2012-05-30 | 郑州豫密药业股份有限公司 | Method for determining contents of saikosaponin a and saikosaponin d in resolving depression pill by high performance liquid chromatography |
CN103197003A (en) * | 2012-01-04 | 2013-07-10 | 天士力制药集团股份有限公司 | Authentication method of Chinese thorowax root medicine material |
-
2014
- 2014-07-31 CN CN201410374865.4A patent/CN104267109A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102475871A (en) * | 2010-11-26 | 2012-05-30 | 郑州豫密药业股份有限公司 | Method for determining contents of saikosaponin a and saikosaponin d in resolving depression pill by high performance liquid chromatography |
CN103197003A (en) * | 2012-01-04 | 2013-07-10 | 天士力制药集团股份有限公司 | Authentication method of Chinese thorowax root medicine material |
Non-Patent Citations (4)
Title |
---|
国家药典委员会: "《中华人民共和国药典 2010年版一部》", 31 January 2010 * |
李冬华 等: "我国市售药材中64种农药残留的本底调查与检测分析", 《西部中医药》 * |
茅仁刚 等: "HPLC法测定不同品种柴胡中的柴胡皂苷a、c、d的含量", 《中草药》 * |
鲁湘鄂 等: "HPLC法测定柴胡中柴胡皂苷a,d的含量", 《肇庆学院学报》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104698098A (en) * | 2015-02-12 | 2015-06-10 | 吉林敖东中药饮片股份有限公司 | Bupleurum chinense content determination method |
CN109270258A (en) * | 2018-10-31 | 2019-01-25 | 武汉利恩达医疗科技有限公司 | A kind of saikosaponin D Test paper preparation method |
CN111089913A (en) * | 2019-10-16 | 2020-05-01 | 四川恒通动保生物科技有限公司 | Quality control method of bupleurum chinense injection |
CN113030340A (en) * | 2021-04-09 | 2021-06-25 | 北京市药品检验所 | Method for measuring content of characteristic components of radix bupleuri in radix bupleuri and preparation thereof by liquid phase coupling high-resolution mass spectrometry |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104267110A (en) | Chinese angelica medicinal material detection method | |
CN102735784B (en) | Method for simultaneously determining one hundred pesticide residuals in traditional Chinese medicine through ultrahigh performance liquid chromatography-tandem quadrupole mass spectrum | |
CN104198600A (en) | Method for detecting radix astragali | |
Wang et al. | Analysis of eight organophosphorus pesticide residues in fresh vegetables retailed in agricultural product markets of Nanjing, China | |
CN107589203B (en) | Method for simultaneously detecting three cannabinol compounds in hemp by SPE-HPLC | |
CN107576732B (en) | Method for determining glyphosate, aminomethylphosphonic acid and glufosinate in food | |
CN106353418B (en) | A method of 28 kinds of pesticide residues in dark brownish green are measured simultaneously with the triple level four bars second order ms of gas-chromatography- | |
CN104535665A (en) | Detection method of radix codonopsis medicinal material | |
CN106483232A (en) | The method for quick of Multiple Pesticides residual in a kind of soil | |
CN104267109A (en) | Radix bupleuri medicinal material detection method | |
CN105784894B (en) | Pesticide residue detection method for traditional Chinese medicine | |
CN105548431A (en) | Method for simultaneously detecting residual quantities of oxamyl and oxamyl oxime in vegetable/fruits | |
CN101564681A (en) | Solid phase extraction column of chloromycetin molecularly imprinted polymer and preparation method thereof | |
Zhou et al. | Molecularly Imprinted Nanomicrospheres as Matrix Solid‐Phase Dispersant Combined with Gas Chromatography for Determination of Four Phosphorothioate Pesticides in Carrot and Yacon | |
Wang et al. | Generic imprinted fiber array strategy for high-throughput and ultrasensitive simultaneous determination of multiple neonicotinoids | |
CN104267111A (en) | Pinellia ternate medicinal material detection method | |
CN104198599A (en) | Method for detecting glycyrrhiza uralensis | |
CN102798682B (en) | Method for determination of flumethrin in garlic or garlic product | |
CN109828051A (en) | A kind of detection method of toxic compounds | |
CN104458931B (en) | A kind of detection method of chromatogram of Radix Isatidis | |
CN109884199B (en) | Method for measuring content of flavonoid components in honey | |
CN107561194A (en) | A kind of more Fast Determination of Pesticide Residue methods of fruits and vegetables | |
CN103217498A (en) | Method for detecting dicyandiamide in milk powder with LC-MS (liquid chromatography/mass spectrometry) and sample preparation method | |
CN110243984A (en) | A kind of strawberry pesticide residues detection method | |
CN112051343B (en) | Method for determining antibiotic residues |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150107 |
|
RJ01 | Rejection of invention patent application after publication |